Log In
Print
BCIQ
Print
Print this Print this
 

IDX21437

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionUridine nucleotide analog HCV NS5B polymerase inhibitor
Molecular Target HCV NS5B polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationHepatitis
Indication DetailsTreat HCV genotypes 1, 2 or 3 infection; Treat HCV infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today